This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Khalkhali-Ellis, Z. Articles by Hendrix, M. J. C. Search for Related Content PubMed PubMed Citation Articles by Khalkhali-Ellis, Z. Articles by Hendrix, M. J. C.

(American Journal of Pathology. 2003;162:1411-1417.)
© 2003 American Society for Investigative Pathology

Short Communications

Nitric Oxide Regulation of Maspin Expression in Normal Mammary Epithelial and Breast Cancer Cells

Zhila Khalkhali-Ellis^* and Mary J. C. Hendrix^*

From the Department of Anatomy and Cell Biology^*and the Holden Comprehensive Cancer Center at The University of Iowa,Carver College of Medicine, The University of Iowa, Iowa City, Iowa

In this study, we examined the unique relationship of maspin, a serine protease inhibitor (serpin), that plays a critical role in mammary gland development and is silenced during breast cancer progression, and nitric oxide (NO), a multifaceted water and lipid soluble free radical. The hypothesis tested was that there is a correlation between endothelial nitric oxide synthase and maspin in MCF-7 cells and that NO is capable of regulating maspin expression. An experimental system was developed in which cellular levels of NO in normal human mammary epithelial cells and the breast cancer cell line MCF-7 could be altered using NO modulators. The effect(s) of NO modulators on maspin was measured using reverse transcriptase-polymerase chain reaction and Western blot analysis of subcellular fractions of both cell types. The data revealed that NO induced maspin expression in MCF-7 cells, and the induced maspin resulted in diminished cell motility and invasion, concomitant with an increase in the apoptotic index. This novel finding provides new information regarding the molecular role of maspin in regulating mammary epithelial growth, remodeling, tumor progression, and the metastatic process. More significantly, these findings could have a potential impact on future therapeutic intervention strategies for breast cancer. Targeted delivery of NO within the tumor microenvironment could provide a feasible noninvasive approach for effective treatment.

This article has been cited by other articles:

				J. Ahn, C. B. Ambrosone, P. A. Kanetsky, C. Tian, T. A. Lehman, S. Kropp, I. Helmbold, D. von Fournier, W. Haase, M. L. Sautter-Bihl, et al. Polymorphisms in Genes Related to Oxidative Stress (CAT, MnSOD, MPO, and eNOS) and Acute Toxicities from Radiation Therapy following Lumpectomy for Breast Cancer Clin. Cancer Res., December 1, 2006; 12(23): 7063 - 7070. [Abstract] [Full Text] [PDF]

				A. Dokras, J. Coffin, L. Field, A. Frakes, H. Lee, A. Madan, T. Nelson, G.-Y. Ryu, J.-G. Yoon, and A. Madan Epigenetic regulation of maspin expression in the human placenta Mol. Hum. Reprod., October 1, 2006; 12(10): 611 - 617. [Abstract] [Full Text] [PDF]

				Z. Khalkhali-Ellis, A. L. Christian, D. A. Kirschmann, E. M. Edwards, M. Rezaie-Thompson, M. A. Vasef, L. M. Gruman, R. E. B. Seftor, L. E. Norwood, and M. J. C. Hendrix Regulating the Tumor Suppressor Gene Maspin in Breast Cancer Cells: A Potential Mechanism for the Anticancer Properties of Tamoxifen Clin. Cancer Res., January 15, 2004; 10(2): 449 - 454. [Abstract] [Full Text] [PDF]